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Abstract 
Cytokeratins  (CK)  are  good  markers  of
epithelial  tumors,  and  most  of  carcinomas
including  small  cell  lung  carcinoma  (SCLC)
expresses  CK.  Herein  reported  is  a  case  of
SCLC without CK expression.
Case Report
A 67-year-old man presented with cough and
sputum.  Imaging  modalities  revealed  a  large
mass (10 cm in diameter) in the right upper
lobe of the lung (Figure 1). Lung carcinoma was
suspected,  but  repeated  transbronchial  lung
biopsies and sputum cytologies failed to reveal
carcinoma cells. Therefore, CT-guided needed
biopsy  was  performed.  The  biopsy  showed
medullary small epithelioid malignant cells with
scant  cytoplasm,  hyperchromatic  nuclei  and
inconspicuous nucleoli (Figure 2). Mitotic fig-
ures and necrotic areas were scattered. The his-
tological diagnosis was SCLC. An immunohisto-
chemical study was performed with the use of
Dako  Envision  method,  as  previously
described.
1,2 The tumor cells were positive for
synaptophysin  (Figure  3A),  PDGFRA  (Figure
3B)  and  Ki-67  (labeling=80%)  (Figure  3C).
However, they were negative for panCK (AE1/3,
CAM5.2,  WSS,  MNF116),  CK  34BE12,  CK5/6,
CK7, CK8, CK14, CK18, CK19, CK20, EMA, p63,
p53, CEA, CA19-9, CD45, CD3, CD20, CD45RO,
CD79α,  CD138,  κ-chain,  λ-chain,  vimentin,
desmin,  smooth  muscle  actin,  S100  protein,
HMB45, CD34, myoglobin, neuron-specific eno-
lase,  CD56  (NCAM),  chromogranin,  KIT
(CD117),  MIC-2  (CD99),  TTF-1,  CDX2,  calre-
tinin, D2-40, and bcl-2. Although CK was nega-
tive, the author diagnosed the tumor as SCLC
because  histology  was  compatible  with  SCLC
and also because synaptophysin and PDGFRA
were positive. The patient is now treated with
cisplatin-based chemotherapy.
The  present  case  of  SCLC  indicates  that
SCLC  can  be  negative  for  CK.
3,4 Differential
diagnosis was sarcoma. As a whole, the current
case seems not to be sarcoma because of lack
of vimentin immunoreactivity. Lipogenic, myo-
genic, and neurogenic sarcomas were unlikely
because their immunohistochemical markers
were  negative.  Malignant  lymphoma  is  also
unlikely  because  of  the  lack  of  lymphocytic
markers. Plasmacytoma is unlikely because of
the lack of light chains and CD138. Malignant
melanoma is unlikely because of the lack of
S100 protein and HMB45. PNET/Ewing sarco-
ma is unlikely because the tumor cells were
negative for MIC-2. Other kinds of sarcoma are
also unlikely.
Differential diagnosis from pulmonary car-
cinomas is also important. The present case is
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Figure 1. Chest computed tomography. A
large tumor (10 cm in diameter) is seen in
the anterior aspect of the right upper lobe.
Figure 2. Biopsy histology. The tumor cells are medullary and epithelioid. The tumor cells
are small and had scant cytoplasm, hyperchromatic nuclei, and inconspicuous nucleoli.
HE, A; x50. B;x200.
Figure 3. Immunohistocheimical findings.
The tumor cells are positive for synapto-
physin (A), PDGFRA (B), and Ki67 anti-
gen (labeling=80%) (C). Immunostaining,
x200.
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different from large cell neuroendocrine carci-
noma because of tumor cell size and histology.
The present case is not poorly differentiated
squamous cell carcinoma or adenocarcinoma.
The present case is not sarcomatoid carcino-
mas of the lung. The present case is not malig-
nant mesothelioma because the present case
was negative for D2-40 and calretinin.
The author believes that the present case is
CK-negative SCLC.
In conclusion, pulmonary SCLC can be neg-
ative for CK. In such a case, extensive differen-
tial diagnosis is required. 
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